Nasdaq Obio News Today

Orchestra BioMed (NASDAQ:OBIO – Get Free Report) is one of 226 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Orchestra BioMed to related businesses based on the strength of its analyst recommendations, institutional ownership, valuation, risk, dividends, profitability and earnings. Earnings and Valuation […]

Orchestra BioMed (NASDAQ:OBIO – Get Free Report) is one of 226 public companies in the “Surgical & medical instruments” industry, but how does it compare to its competitors? We will compare Orchestra BioMed to similar companies based on the strength of its analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. Volatility and Risk […]

Jefferies Financial Group started coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Free Report) in a report published on Friday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $14.00 target price on the stock. Orchestra BioMed Stock Performance Shares of OBIO opened at $8.72 on Friday. The stock has a 50-day moving […]

NEW HOPE, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical...

Orchestra BioMed (NASDAQ:OBIO – Get Free Report) and ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of […]

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Free Report) saw a large growth in short interest in June. As of June 15th, there was short interest totalling 366,100 shares, a growth of 76.3% from the May 31st total of 207,700 shares. Based on an average daily trading volume, of 75,700 shares, the days-to-cover ratio is presently […]

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Get Rating)’s share price shot up 8.2% during trading on Thursday . The stock traded as high as $16.36 and last traded at $16.23. 43,222 shares changed hands during trading, a decline of 50% from the average session volume of 86,234 shares. The stock had previously closed at $15.00. […]

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO – Get Rating) – Stock analysts at Lifesci Capital issued their Q2 2023 earnings per share estimates for shares of Orchestra BioMed in a report issued on Monday, May 15th. Lifesci Capital analyst R. Rakhit anticipates that the company will post earnings per share of ($0.38) for the quarter. Lifesci […]

Piper Sandler started coverage on shares of Orchestra BioMed (NASDAQ:OBIO – Get Rating) in a research note released on Friday morning, The Fly reports. The firm issued an overweight rating and a $15.00 price target on the stock. Separately, Chardan Capital began coverage on shares of Orchestra BioMed in a report on Tuesday, February 7th. […]